I've invested in AT1 since IPO because of their generic...

I've invested in AT1 since IPO because of their generic all-in-one device for testing. In a few months they found a new partner (NG Bio) and a new market with covid19. There are so many applications to rapid testing. They will sell everything they can produce for a long long time. If this is not positive for the market then it's a proof that markets are always wrong (until they come back to reality). Atomo is a 10 years old company known in the RDT space for their innovation. DYOR and have some patience at least until they have scaled production ready for announcing new contracts. And don't expect to be only for Covid19.